Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Clinical trial NCT03993678 · COMPLETED

Trial details

NCT number: NCT03993678
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2020-10-12
Primary completion: 2025-07-15
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.